Qualified Health raises $125M in Series B

Qualified Health, a provider of secure artificial intelligence platforms for health systems, has secured $125 million in a Series B funding round led by New Enterprise Associates. The funding aims to scale Qualified Health's capability to integrate AI within healthcare operations across the United States. The round also saw participation from new investors including Transformation Capital, GreatPoint Ventures, Cathay Innovation, and Anthology Fund, along with existing stakeholders.

The company, which was established in 2023, focuses on offering out-of-the-box AI solutions for enterprise health systems. These integrations are designed to reduce the need for costly, potentially unsuccessful pilots that necessitate staff retraining and revert processes. Qualified Health's platform already facilitates more than 500,000 active users and accounts for about 7% of hospital revenue generated in the United States, serving major partners such as Mercy, Emory Healthcare, University of Rochester Medicine, Jefferson Health, and the University of Texas System.

CEO Justin Norden emphasized the transformational impact that Qualified Health seeks to deliver in healthcare delivery. The firm's strategy focuses on deepening partnerships and demonstrating AI’s potential to lower costs while improving patient outcomes. According to Norden, health systems are not looking for minor enhancements but instead aim for fundamental change in care delivery methodologies.

The infusion of funds comes against the backdrop of a rapidly expanding global AI healthcare market. According to Grand View Research projections, the market's valuation could soar to $506 billion by 2033, with the U.S. market spearheading this growth due to increased adoption of AI technologies by 79% of healthcare organizations. Though the pandemic accelerated AI adoption, projected future growth is driven by a looming shortage of healthcare workers, predicted to reach a deficit of 10 million by 2033.

Qualified Health highlights that its platform is engineered with built-in safety and governance measures, ensuring oversight by medical professionals and providing traceability of decision-making processes. As health systems evolve, the firm's approach aims to unify disparate data sources, transition manual operations to automated systems, and embed AI into daily patient interactions. Looking ahead, the company plans to tackle these organizational and cultural shifts by further advancing their technology and partnerships in the sector.